Modulation = Moderation
Xoma Thinks 'Dimmer Switch' Antibodies Have Bright Future
By Anette Breindl
Wednesday, March 14, 2012
Researchers from XOMA Corp. have identified an antibody that, in preclinical experiments, improved glucose control and other symptoms of diabetes.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.